Introduction
Methods
Ethical consideration
Study population
Inclusion criteria
Exclusion criteria
Groups and definitions
Outcome
Statistical analysis
Results
Study population
n | 75 |
---|---|
Age at injury, years (mean (SD)) | 49.92 (± 17.56) |
Female gender [n (%)] | 42 (56.0) |
LOS, days [mean (SD)] | 13.40 (± 12.89) |
Multiple injured (ISS ≥ 16 points) [n (%)] | 30 (40.0) |
ISS, points [mean (SD)] | 12.83 (± 8.26) |
AIS extremity, points [mean (SD)] | 2.72 (± 0.71) |
TBI [n (%)] | |
1° (Mild) | 60 (80.0) |
2° (Moderate) | 6 (8.0) |
3° (Severe) | 9 (12.0) |
Neer [n (%)] | |
2 | 14 (18.7) |
3 | 38 (50.7) |
4 | 23 (30.7) |
Follow-up time, years (mean (SD)) | 5.94 (± 3.33) |
Impact of multiple injuries on functional outcome and quality of life
Group I/M-H | Group PT–H | p value | |
---|---|---|---|
n | 45 | 30 | |
Age at injury, years [mean (SD)] | 54.73 (± 17.46) | 42.72 (± 15.33) | 0.003 |
Female gender [n (%)] | 34 (± 75.6) | 8 (± 26.7) | < 0.001 |
LOS, days [mean (SD)] | 7.82 (± 5.68) | 21.77 (± 15.95) | < 0.001 |
ISS, points [mean (SD)] | 6.89 (± 2.50) | 21.73 (± 5.26) | < 0.001 |
AIS extremity, points [mean (SD)] | 2.58 (± 0.50) | 2.93 (± 0.91) | n.s |
TBI [n (%)] | n.s | ||
1° (Mild) | 41 (91.1) | 19 (63.3) | |
2° (Moderate) | 1 ( 2.2) | 5 (16.7) | |
3° (Severe) | 3 ( 6.7) | 6 (20.0) | |
Neer [n (%)] | n.s | ||
2 | 9 (20.0) | 5 ( 16.7) | |
3 | 23 (51.1) | 15 ( 50.0) | |
4 | 13 (28.9) | 10 ( 33.3) |
Outcome parameter
Group I/M-H | Group PT–H | p value | |
---|---|---|---|
n | 45 | 30 | |
Age at questioning, years [mean (SD)] | 60.91 (± 16.80) | 48.30 (± 15.13) | 0.001 |
Follow-up, years [mean (SD)] | 6.18 (± 3.47) | 5.58 (± 3.14) | n.s |
DASH-Score [mean (SD)] | 9.86 (± 13.12) | 12.43 (± 15.51) | n.s |
EQ-5D-3L [mean (SD)] | 0.86 (± 0.23) | 0.72. (± 0.26) | 0.017 |
EQ-VAS [mean (SD)] | 78.13 (± 19.77) | 74.13 (± 19.43) | n.s |
Group I/M-H | Group PT–H | ||
---|---|---|---|
n | 45 | 30 | |
Retroversion [mean (SD)] | 29.78 (± 11.94) | 39.44 (± 6.98) | n.s |
Flexion [mean (SD)] | 133.06 (± 29.86) | 145.37 (± 42.99) | n.s |
Abduction [mean (SD)] | 119.72 (± 35.00) | 142.41 (± 42.46) | n.s |
Adduction [mean (SD)] | 43.28 (± 12.24) | 38.30 (± 7.66) | n.s |
External Rotation [mean (SD)] | 59.17 (± 16.65) | 61.11 (± 19.43) | n.s |
Internal Rotation [mean (SD)] | 73.53 (± 16.56) | 74.81 (± 19.68) | n.s |
Co-variables | Beta-coefficient | 95% CI | p value | |
---|---|---|---|---|
EQ-5D-3L | ISS > 16 | 0.86 | 0.75–0.99 | 0.041 |
Sex (female) | 0.95 | 0.83–1.10 | n.s | |
Age at injury | 1.00 | 1.00–1.01 | n.s | |
Minor TBI | Reference | |||
Moderate TBI | 1.00 | 0.80–1.24 | n.s | |
Severe TBI | 1.03 | 0.86–1.24 | n.s | |
EQ-VAS | ISS > 16 | − 5.63 | 5.89 to − 0.96 | n.s |
SEX (female) | 1.28 | 5.70–0.22 | n.s | |
Age at injury | − 0.09 | 0.15 to − 0.59 | n.s | |
Minor TBI | Reference | |||
Moderate TBI | 7.69 | 9.05–0.85 | n.s | |
Severe TBI | 0.61 | 7.44–0.08 | n.s | |
DASH | ISS > 16 | 5.66 | 4.18–1.36 | n.s |
SEX (female) | 2.73 | 4.04–0.68 | n.s | |
Age at injury | 0.14 | 0.11–1.311 | n.s | |
Minor TBI | Reference | |||
Moderate TBI | 0.65 | 6.41–0.10 | n.s | |
Severe TBI | − 1.42 | 5.27 to − 0.27 | n.s |
Discussion
Functional outcome
Group I/M-H | Group PT–H | |||||||
---|---|---|---|---|---|---|---|---|
Mild | Moderate | Severe | p | Mild | Moderate | Severe | p | |
n | 41 | 1 | 3 | 19 | 5 | 6 | ||
Age at injury, years [mean (SD)] | 53.56 (17.41) | 52.73 (NA) | 71.38 (14.20) | NA | 44.09 (14.23) | 42.83 (22.59) | 38.28 (13.99) | n.s |
Female gender [n (%)] | 31 ( 75.6) | 1 (100.0) | 2 ( 66.7) | n.s | 3 ( 15.8) | 2 ( 40.0) | 3 ( 50.0) | n.s |
LOS, days [mean (SD)] | 6.80 (4.41) | 10.00 (NA) | 21.00 (6.08) | NA | 21.37 (17.86) | 21.40 (12.16) | 23.33 (14.36) | n.s |
Neer [n (%)] | n.s | n.s | ||||||
2 | 8 ( 19.5) | 0 ( 0.0) | 1 ( 33.3) | 5 ( 26.3) | 0 ( 0.0) | 0 ( 0.0) | ||
3 | 23 ( 56.1) | 0 ( 0.0) | 0 ( 0.0) | 10 ( 52.6) | 2 ( 40.0) | 3 ( 50.0) | ||
4 | 10 ( 24.4) | 1 (100.0) | 2 ( 66.7) | 4 ( 21.1) | 3 ( 60.0) | 3 ( 50.0) | ||
ISS, points [mean (SD)] | 6.93 (2.49) | 4.00 (NA) | 7.33 (2.89) | NA | 21.37 (4.83) | 22.00 (5.79) | 22.67 (6.95) | n.s |
Follow-up time, years [mean (SD)] | 6.13 (3.42) | 10.27 (NA) | 5.62 (4.74) | NA | 5.38 (3.06) | 6.57 (3.62) | 5.39 (3.44) | n.s |
EQ-VAS [mean (SD)] | 78.44 (19.88) | 90.00 (NA) | 70.00 (22.91) | NA | 71.58 (22.11) | 79.80 (20.68) | 77.50 (4.18) | n.s |
DASH [mean (SD)] | 9.80 (13.34) | 0.83 (NA) | 13.74 (12.69) | NA | 12.46 (16.55) | 15.67 (19.94) | 9.63 (8.39) | n.s |
EQ-VAS [mean (SD)] | 0.85 (0.23) | 1.00 (NA) | 0.92 (0.14) | NA | 0.73 (0.28) | 0.67 (0.30) | 0.73 (0.22) | n.s |